Medical

Cardiovascular Health

ReOxy® is the only evidence-based medical device that improves exercise capacity and cardiovascular health in patients with coronary artery disease (CAD). It improve functional capacity when traditional exercice alone might be insufficient or risky.

EU Commission evaluation highly ranked ReOxy® project as a game changer in cardiac rehabilitation (HORIZON 2020 Programme).

A 5-week ReOxy®-based IHHT® program was found to be as effective as an 8-week exercise-based rehabilitation program in improving VO2 peak in older cardiac patients who were unable to perform regular exercise (Source)

Clinical Trial Results	Patients Benefits	Reference
Increases 6 minutes walking test distance	Greater walking ability and endurance with less fatigue during physical activity	Source [6]
Increases aerobic capacity (VO2 peak)	Better cardiovascular fitness, improved endurance, similar effectiveness as traditional exercise rehab	Source [7]
Reduces systolic and diastolic blood pressure	Lower risk of heart attack and stroke, improved heart health	Source [9]
Enhances exercise tolerance and reduces angina symptoms	Greater ability to perform daily activities with less exertion	Source [8]

Respiratory Health

ReOxy® therapy has as shown benefits in long-COVID patients in a pilot clinical trial

Clinical Trial Results	Patients Benefits
Increased 6-minute walking test distance (+91.7m in IHHT group vs. +32.6m in control)	Better mobility and endurance, improved functional recovery
Improved stair climbing power  (3.7-fold improvement vs. control)	Greater ability to perform daily activities with less exertion
Reduced dyspnea  (Borg scale improvement 2x greater than control)	Greater ability to perform daily activities with less exertion

Cognitive Function

ReOxy® therapy has been clinically shown to enhance cognitive performance in elderly patients, supporting improved memory, attention, and executive function.

ReOxy is a non-invasive, well-tolerated intervention that can be seamlessly integrated into multimodal rehabilitation programs.

Key findings from a randomized controlled study (ages 64–92):

+16.7% improvement in DemTect scores 

Indicating a significant enhancement in global cognitive performance.
+10.7% improvement in Clock Drawing Test scores 

Reflecting gains in visual-spatial processing, memory, attention, and executive functioning (core domains of daily cognitive competence).
Increased 6-minute walk test distance and reduced perceived pain 

Improvements in physical capacity and pain management, both associated with better cognitive outcomes.

Medical

Cardiovascular Health

Respiratory Health

Cognitive Function

Key findings from a randomized controlled study (ages 64–92):

+16.7% improvement in DemTect scores

+10.7% improvement in Clock Drawing Test scores

Increased 6-minute walk test distance and reduced perceived pain

ReOxy®

is the sole device in its class with benefits demonstrated in clinical studies

Breathe. Live Better

Sitemap

Contact